Tanespimycin-d5
Tanespimycin-d5 (17-AAG-d5; NSC 330507-d5; CP 127374-d5) is the deuterium labeled Tanespimycin. Tanespimycin (17-AAG) is a potent HSP90 inhibitor with an IC50 of 5 nM, having a 100-fold higher binding affinity for tumour cell derived HSP90 than normal cell derived HSP90[1][5]. Tanespimycin depletes cellular STK38/NDR1 and reduces STK38 kinase activity. Tanespimycin also downregulates the stk38 gene expression[3].
Product Specifications
Product Name Alternative
17-AAG-d5; NSC 330507-d5; CP 127374-d5
UNSPSC
12352005
Target
Antibiotic; Apoptosis; Autophagy; Bacterial; HSP; Isotope-Labeled Compounds; Mitophagy
Related Pathways
Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others
Field of Research
Cancer
Smiles
O=C(C(NC(/C(C)=C/C=C\[C@H](OC)[C@H](/C(C)=C/[C@@H]([C@H]([C@H](C[C@@H](C1)C)OC)O)C)OC(N)=O)=O)=CC2=O)C1=C2NC([2H])([2H])/C([2H])=C([2H])/[2H]
Molecular Formula
C31H38D5N3O8
Molecular Weight
590.72
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD79b (B-Cell Marker) (IGB/2940R), CF594 conjugate, 0.1mg/mL
